Kinetic modeling of [11C]laniquidar in human brain - A novel PET tracer for P-gp expression

被引：0

作者：

Postnov, Andre ^{[1
]}

Froklage, F. ^{[2
]}

Boellaard, Ronald ^{[1
]}

Schuit, Robert ^{[1
]}

Eriksson, Jonas ^{[1
]}

Windhorst, Albert ^{[1
]}

Voskuyl, Rob ^{[3
]}

van Berckel, Bart ^{[1
]}

Lammertsma, Adriaan ^{[1
]}

机构：

[1] Vrije Univ Amsterdam, Nucl Med & PT Res, Med Ctr, Amsterdam, Netherlands

[2] Vrije Univ Amsterdam, Neurol, Med Ctr, Amsterdam, Netherlands

[3] Leiden Amsterdam Ctr Drug Res, Fac Sci, Pharmacol, Leiden, Netherlands

来源：

JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

548

引用

页数：2

共 50 条

[21] BRAIN P-GLYCOPROTEIN FUNCTION STUDIED IN RATS WITH TWO NOVEL PET RADIOTRACERS: [11C]QUINIDINE AND [11C]LANIQUIDAR. DIFFERENCES BETWEEN CONTROLS AND EPILEPTIC RESPONDERS AND NON-RESPONDERS
Voskuyl, R. A.
Syvanen, S.
Russmann, V.
Verbeek, J.
Eriksson, J.
Schuit, R.
Windhorst, A. D.
Labots, M.
Rongen, M.
Lammertsma, A. A.
De Lange, E. C.
Potschka, H.
EPILEPSIA, 2012, 53 : 131 - 132
[22] Synthesis and evaluation of novel PET probes for P-gp expression and function
van Waarde, Aren
Ramakrishnan, Nisha
Elsinga, Philip
Berardi, Francesco
Willemsen, Antoon
Perrone, Roberto
Cantore, Mariangela
Dierckx, Rudi
Colabufo, Nicola
JOURNAL OF NUCLEAR MEDICINE, 2009, 50
[23] The influence of mass of [11C]-laniquidar and [11C]-N-desmethyl-loperamide on P-glycoprotein blockage at the blood-brain barrier
Moerman, Lieselotte
Dumolyn, Caroline
Boon, Paul
De Vos, Filip
NUCLEAR MEDICINE AND BIOLOGY, 2012, 39 (01) : 121 - 125
[24] In vitro evaluation of the new P-gp tracer [18F]MC210 and comparison to (R)-[11C]verapamil
Savolainen, Heli
Benadiba, Marcel
Kwizera, Chantal
Elsinga, Philip H.
Windhorst, Albert D.
Lammertsma, Adriaan A.
Cantore, Mariangela
Colabufo, Nicola A.
Luurtsema, Gert
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S334 - S334
[25] Robust kinetic model for quantification of P-glycoprotein (P-gp) function under altered metabolism and after P-gp inhibition using (R)[C-11]verapamil and PET
Wang, Shaonan
Feldmann, Maria
Hinz, Rainer
McMahon, Adam
Koepp, Matthias
Jackson, Alan
Asselin, Marie-Claude
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 : S169 - S170
[26] Validation of [11C]ORM-13070 as a PET Tracer for Alpha2c-Adrenoceptors in the Human Brain
Lehto, Jussi
Hirvonen, Mika M.
Johansson, Jarkko
Kemppainen, Jukka
Luoto, Pauliina
Naukkarinen, Tarja
Oikonen, Vesa
Arponen, Eveliina
Rouru, Juha
Sallinen, Jukka
Scheinin, Harry
Vuorilehto, Lauri
Finnema, Sjoerd J.
Halldin, Christer
Rinne, Juha O.
Scheinin, Mika
SYNAPSE, 2015, 69 (03) : 172 - 181
[27] Exploration of analogs of [11C]dLop as potential probes for measuring increased P-gp function
Cai, Lisheng
Peng, Yiyuan
Xie, Yepeng
Hong, Jinsoo
Liow, Jeih-San
Deuitch, Lora
Hall, Matthew
Innis, Robert
Pike, Victor W.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2015, 58 : S308 - S308
[28] Evaluation of tracer kinetic models for quantification of P-glycoprotein function using (R)-[11C]verapamil and PET
Lubberink, Mark
Luurtsema, Gert
van Berckel, Bart N. M.
Boellaard, Ronald
Toornvliet, Rolf
Windhorst, Albert D.
Franssen, Eric J. F.
Lammertsma, Adriaan A.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2007, 27 (02) : 424 - 433
[29] Biodistribution, dosimetry and brain kinetics of [11C]-JNJ-63779586, a bace inhibitor and sensitive P-gp and BCRP substrate
Mertens, N.
Schmidt, M.
Bormans, G.
Van Laere, K.
Mannaert, E.
Koole, M.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 : 607 - 608
[30] Inhibition of P-gp and BCRP-mediated efflux transport of [11C] erlotinib at the non-human primate blood-brain barrier
Tournier, N.
Goutal, S.
Auvity, S.
Traxl, A.
Mairinger, S.
Wanek, T.
Buvat, I.
Soussan, M.
Caille, F.
Langer, O.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S99 - S99

← 1 2 3 4 5 →